5/5GROOVE BOTANICALS INC. (GRVE): Non-reliance / restatement

Market data

Price before filing: $0.0053 (2025-08-18 close, split/dividend-adjusted)
Market cap at flag: $316,108 (2025-08-19) · Latest: $298,215 (2026-10-15)

What happened next

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Insider trading around this filing

90 days before the flag: no open-market insider sales or purchases reported.
30 days after: none reported.

Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-05-21 to 2025-09-18. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.

Verified excerpt

"We filed the Original Report without the written consent of our auditors and therefore the Original Report should not be relied upon."

Quoted from the filing. Source

What this means

The company says previously issued financial statements should no longer be relied upon (8-K Item 4.02). This is one of the most serious accounting red flags: past reported numbers were wrong and will be restated.

Why this score: also within 90 days: Going-concern doubt, Late annual report (NT 10-K)